Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Plasma Amyloid-Β As A Biomarker In Alzheimer's Disease: The Aibl Study Of Aging , James Lui, Simon Laws, Qiao-Xin Li, Victor Villemagne, David Ames, Belinda Brown, Ashley Bush, Karl De Ruyck, Jasmin Dromey, Kathryn Ellis, Noel Faux, Jonathan Foster, Christopher Fowler, Veer Gupta, Peter Hudson, Katrina Laughton, Colin Masters, Kelly Pertile, Alan Rembach, Miroslava Rimajova, Mark Rodrigues, Christopher Rowe, Rebecca Rumble, Cassandra Szoecke, Kevin Taddei, Tania Taddei, Brett Trounson, Vanessa Ward
Plasma Amyloid-Β As A Biomarker In Alzheimer's Disease: The Aibl Study Of Aging , James Lui, Simon Laws, Qiao-Xin Li, Victor Villemagne, David Ames, Belinda Brown, Ashley Bush, Karl De Ruyck, Jasmin Dromey, Kathryn Ellis, Noel Faux, Jonathan Foster, Christopher Fowler, Veer Gupta, Peter Hudson, Katrina Laughton, Colin Masters, Kelly Pertile, Alan Rembach, Miroslava Rimajova, Mark Rodrigues, Christopher Rowe, Rebecca Rumble, Cassandra Szoecke, Kevin Taddei, Tania Taddei, Brett Trounson, Vanessa Ward
Simon Laws
Amyloid-β (Aβ) plays a central role in the pathogenesis of Alzheimer's disease (AD) and has been postulated as a potential biomarker for AD. However, there is a lack of consensus as to its suitability as an AD biomarker. The objective of this study was to determine the significance of plasma Aβ as an AD biomarker and its relationship with Aβ load and to determine the effect of different assay methods on the interpretation of Aβ levels. Plasma Aβ1-40, Aβ1-42, and N-terminal cleaved fragments were measured using both a commercial multiplex assay and a well-documented ELISA in 1032 individuals drawn from …